FDA approves first generic Strattera for the treatment of ADHD

By Newsroom America Feeds at 30 May 2017

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm561096.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL